Showing results (2021-2030 of 2,072) with videos related to
Sort By:
Pageof 208
Nature Catalysis|December 5, 2022
Bypassing evolutionary dead ends and switching the rate-limiting step of a human immunotherapeutic enzymeJohn Blazeck, Christos S Karamitros, Kyle Ford, et al.Journal of Ethnopharmacology|February 2, 2021
Efficacy and safety assessment of severe COVID-19 patients with Chinese medicine: A retrospective case series study at early stage of the COVID-19 epidemic in Wuhan, ChinaYu Wang, Cheng Lu, Hao Li, et al.Signal Transduction and Targeted Therapy|March 17, 2023
Toripalimab combined with lenvatinib and GEMOX is a promising regimen as first-line treatment for advanced intrahepatic cholangiocarcinoma: a single-center, single-arm, phase 2 studyGuo-Ming Shi, Xiao-Yong Huang, Dong Wu, et al.Frontiers in Immunology|September 16, 2021
CTLA-4 Synergizes With PD1/PD-L1 in the Inhibitory Tumor Microenvironment of Intrahepatic CholangiocarcinomaXiao-Jun Guo, Jia-Cheng Lu, Hai-Ying Zeng, et al.Nature Communications|May 20, 2022
Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editingColin McGaw, Anthony J Garrity, Gabrielle Z Munoz, et al.Scientific Reports|January 26, 2017
Epigenetic map and genetic map basis of complex traits in cassava populationMeiling Zou, Cheng Lu, Shengkui Zhang, et al.Nature Immunology|March 22, 2022
Loss of the intracellular enzyme QPCTL limits chemokine function and reshapes myeloid infiltration to augment tumor immunityRosa Barreira da Silva, Ricardo M Leitao, Ximo Pechuan-Jorge, et al.BMC Nephrology|June 17, 2015
Risk factors and their interaction on chronic kidney disease: A multi-centre case control study in TaiwanSui-Lung Su, Chin Lin, SenYeong Kao, et al.Nature Biotechnology|July 17, 2018
Reversal of indoleamine 2,3-dioxygenase-mediated cancer immune suppression by systemic kynurenine depletion with a therapeutic enzymeTodd A Triplett, Kendra C Garrison, Nicholas Marshall, et al.Nature Biotechnology|January 7, 2022
Conformation-locking antibodies for the discovery and characterization of KRAS inhibitorsChristopher W Davies, Angela J Oh, Rana Mroue, et al.Pageof 208